Exciting insights from the OIS Retina Panel! Moderated by Dr. Emmett Cunningham, this discussion dives deep into the current state of ophthalmology investment and innovation. Panelists, Anna Chen, Adit Ghosh, Dr. Firas Rahhal and Caroline Stout shared their perspectives on the evolving landscape, highlighting both opportunities and challenges in the field.

Here are the key takeaways:

• Cautious Optimism: A resurgence in private markets, but drug development challenges persist.
• Growth Areas: Focus on drug delivery, extended-release biologics, and complement inhibitors for dry AMD/GA.
• Strategic Partnerships: Crucial for commercialization in ophthalmology.
• Emerging Trends: AI’s potential impact and regulatory changes in drug discovery.
• Market Concerns: Uncertainties around gene therapy and commercial viability.

Don’t miss out—listen in now to gain valuable insights!

Don’t miss the OIS Retina Panel, moderated by Dr. Pravin Dugel, “The View from the Street.” Join Dr. Anupam Dalal, Andrew Gitkin, and Cameron Taylor as they discuss the latest in ophthalmology, including:

• Current Challenges: Few blockbuster drugs and limited M&A activity
• Opportunities: Growth potential from recent GA therapy successes
• Strategic Insights: Importance of community and networking

Get valuable insights from industry experts and stay ahead of the curve. Listen in now!

Discover the milestone 400th episode of the OIS podcast with Dr. Firas Rahhal and Dr. Robert Rothman, where they explore the impact of Ophthalmology Innovation Summit (OIS) on the investment ecosystem:

• Journey of OIS
• Rich Insights
• Collaboration
• Clinical Mastery
• Long-Term Relationships
• Humor and Admiration
• Future of Ophthalmology

Tune in to this episode for a blend of knowledge, inspiration, and laughter as they navigate the future of eye care innovation. Don’t miss out—listen now!